Nanomedicines for dysfunctional macrophage-associated diseases

Hongliang He1, Shobha Ghosh2, Hu Yang3

  • 1Department of Chemical and Life Science Engineering, Virginia Commonwealth University, Richmond, VA 23219, United States.

Summary

Dysfunctional macrophages contribute to numerous diseases. Nanomedicines offer a promising strategy to target these cells, enhancing therapeutic effectiveness for better clinical outcomes.